Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform
Terumo Blood and Cell Technologies and CSL Plasma have announced a collaboration to develop a new plasma collection platform at CSL Plasma's U.S. collection centers. A clinical trial for the investigational plasmapheresis device commenced in April 2021. The introduction of this platform is contingent on U.S. FDA device clearance, with further details to follow. Plasma collected plays a crucial role in therapies for life-threatening conditions, including immune deficiencies and hemophilia. CSL Plasma operates over 300 centers globally, providing vital therapies to patients.
- Collaboration between Terumo Blood and Cell Technologies and CSL Plasma aims to enhance plasma collection efficiency.
- Commencement of a clinical trial for a new plasmapheresis device, signaling advancement in technology.
- Potential for improved treatment options in life-threatening conditions through enhanced plasma collection.
- Introduction of the new platform is dependent on U.S. FDA device clearance, which carries regulatory risks.
- Timeline for market introduction remains uncertain pending FDA approval.
LAKEWOOD, Colo. and BOCA RATON, Fla., April 19, 2021 /PRNewswire/ -- Terumo Blood and Cell Technologies and CSL Plasma today announce a collaboration to deliver a new plasma collection platform at CSL Plasma U.S. collection centers. A clinical trial of the investigational plasmapheresis device began earlier this month, and introduction of the new platform is subject to U.S. Food and Drug Administration device clearance, at which time the parties will provide further comment.
Plasma is a key ingredient for therapies crucial to treating patients around the world suffering from a host of life-threatening conditions, such as primary immune deficiencies, hereditary angioedema, autoimmune diseases, hemophilia and inherited respiratory disease. Plasma is also commonly given to patients experiencing trauma, burns and organ transplant surgeries.
About Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our associates around the world believe in the potential of blood and cells to do even more for patients than they do today. TERUMOBCT.COM
Terumo Blood and Cell Technologies is a subsidiary of Terumo Corporation (TSE:4543), based in Tokyo.
About CSL Plasma
CSL Plasma operates one of the world's largest and most sophisticated plasma collection networks, with more than 300 plasma collection centers in U.S., Europe and China. Plasma collected at CSL Plasma centers is used by CSL Behring for the purpose of manufacturing and delivering its life-saving therapies to people suffering from serious and rare diseases in more than 100 countries.
CSL Plasma, headquartered in Boca Raton, Fla., upholds a tradition of innovation and customer focus. We are committed to our work because people's lives depend on us. CSL Plasma is a subsidiary of CSL Behring, a global biotherapeutics company and a member of the CSL Group of companies.
The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia, employs more than 27,000 people, and delivers its life-saving therapies to people in more than 100 countries. For more information about CSL Plasma, please go to www.CSLPlasma.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/terumo-blood-and-cell-technologies-and-csl-plasma-announce-collaboration-to-deliver-new-plasma-collection-platform-301271779.html
SOURCE Terumo Blood and Cell Technologies; CSL Plasma
FAQ
What is the collaboration between CSL Plasma and Terumo Blood and Cell Technologies?
What is the significance of the new plasmapheresis device?
When did the clinical trial for the new device begin?
What is required for the new platform to be introduced?
How many plasma collection centers does CSL Plasma operate?
What diseases are treated with plasma collected at CSL Plasma centers?
